[Therapy of chronic non-specific respiratory tract diseases. 2. Therapy of infection, oxygen therapy, supplementary therapy].
Based on the pathological findings and functional analysis treatment of chronic non-specific lung disease (CNSLD) consists in improvement of secretion disorders and airways obstruction as well as in antiphlogistic treatment. The agents and drugs for therapy of pulmonary impairment are reviewed, the efficacy, way of administration, and side effects are outlined. Drug therapy is complemented by digitalis, oxygen administration, physical measures, and causative therapy. With these complex therapeutic efforts an effective therapy of chronic non-specific lung diseases is possible.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D003348:Cortisone / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D000860:Hypoxia / Q000628:therapy; D008173:Lung Diseases, Obstructive / Q000188:drug therapy / Q000628:therapy*; D010102:Oxygen Inhalation Therapy; D005082:Physical Exertion; D026741:Physical Therapy Modalities; D013148:Spironolactone / Q000627:therapeutic use
D004071:Digitalis Glycosides; D006993:Hypnotics and Sedatives; D013148:Spironolactone; D000324:Adrenocorticotropic Hormone; D003348:Cortisone
Therapeutische Möglichkeiten bei chronisch-unspezifischen Atemwegserkrankungen. 2. Therapie der Infektion, Sauerstoff-Therapie, ergänzende Therapie